Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 11Unknown 6Terminated 2Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Myeloid 6

Conditions

Breast Neoplasms 1477Neoplasms 999Colorectal Neoplasms 832Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 648Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 339Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 294Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

midostaurin 1Phlebotomy 1Dasatinib 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × OTHER × Mastocytosis, Systemic × Clear all
NCT06210698 2024-01-18

Angioedema Biomarker Research Study

Foundation For Rare Disease Research

Unknown
600 enrolled
Myeloid

Angioedema, Mastocytosis, Urticaria, Mastocytosis, Systemic, Angioedemas, Hereditary

NCT06013683 2023-10-10

A Registry for Patients With Systemic Mastocytosis in China

The First Affiliated Hospital of Soochow University

Unknown
150 enrolled
Myeloid

Mastocytosis, Systemic

NCT05923372 2023-07-12

DALY-MAST

University Hospital, Toulouse

Unknown
160 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 2/3 Unknown
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

University Medical Center Groningen

Phase 2 Unknown
20 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT00979160 2009-09-18

Evaluation of Response of Dasatinib to Treat Mastocytosis

Federico II University

Phase 2 Unknown
30 enrolled
Myeloid

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡